BNF:

13.10.2

Status:

Do Not Prescribe (DNP)

Decision Date:

February 2014

Comments

Amorolfine (GREY) is the preferred topical treatment in fungal nail infections with restricted use for fungal nail infections where systemic therapy is indicated but contraindicated. Not for cosmetic purposes.

Do Not Prescribe (DNP) Drug Classifications

• 1: Are classified by the BNF as 'less suitable for prescribing', and includes anti-malarials (where a private prescription may be provided). Have a lack of data on effectiveness compared with standard therapy
• 5: Less cost-effective than current standard therapy
• 7: Those that are deemed by national publications (e.g. by NHSE/ NHS Clinical Commissioners) of limited value, unless agreed by local agreement

search again